Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sidney Reilly who wrote (872)	10/27/1997 11:30:00 PM
From: Steve Harmon	Read Replies (2) of 2742

To all CIST followers, Great initial IL-1 vaccine results>>>> CIST has contracted another company to test the adjuvant(boasting) effect of IL-1 with an existing influenza vaccine. A two-month study in rats was conducted. In this study, rats which received the vaccine encapsulated with IL-1 had an antibody titer in excess of 10 fold higher than rats receiving the vaccine without IL-1. The higher antibody titer indicated greater immune response to the vaccine which provides a stronger defense to the illness. There were no signs of IL-1 toxicity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next